APA (7th ed.) Citation

MY, W., STC, S., A, F., EJ, C., L, A., R, H., . . . S, T. (2023). Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer. Cancer cell, 41(5), 821. https://doi.org/10.1016/j.ccell.2023.04.005

Chicago Style (17th ed.) Citation

MY, Wu, et al. "Sotrovimab Restores Neutralization Against Current Omicron Subvariants in Patients with Blood Cancer." Cancer Cell 41, no. 5 (2023): 821. https://doi.org/10.1016/j.ccell.2023.04.005.

MLA (9th ed.) Citation

MY, Wu, et al. "Sotrovimab Restores Neutralization Against Current Omicron Subvariants in Patients with Blood Cancer." Cancer Cell, vol. 41, no. 5, 2023, p. 821, https://doi.org/10.1016/j.ccell.2023.04.005.